⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1429407 | 1.00 | — | — | |
| SCHEMBL40887 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL22778013 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL22778011 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL29956197 | 0.97 | — | — | |
| SCHEMBL2650618 | 0.81 | GRIK1 (0.47) | — | |
| SCHEMBL7700595 | 0.80 | GRIK1 (1.00) | — | |
| SCHEMBL27773703 | 0.80 | GRIK1 (0.66) | — | |
| SCHEMBL15310777 | 0.80 | GRIK1 (1.00) | — | |
| SCHEMBL7785618 | 0.80 | GRIK1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074077-A | Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy | 省卫生服务机构 | 2026-05-22 | — | — | CN | claimed |
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | claimed |
| CN-122051971-A | Safety control method and system for new energy power system | 南通职业大学 | 2026-05-15 | — | — | CN | claimed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | claimed |
| EP-4720087-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| CN-121570433-A | Glutamine metabolism regulation nano drug delivery system for enhancing pancreatic cancer targeting and penetration, and preparation method and application thereof | 复旦大学 | 2026-02-27 | — | — | CN | claimed |
| US-12486304-B2 | Peptide ligand targeting carbonic anhydrase IX, peptide construct comprising same, and uses thereof | C-BIOMEX CO., LTD. (KR) | 2025-12-02 | — | — | US | claimed |
| EP-4652180-A2 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Janssen Pharmaceutica NV (BE) | 2025-11-26 | — | — | EP | claimed |
| EP-4652179-A1 | LIPIDATED PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Janssen Pharmaceutica NV (BE) | 2025-11-26 | — | — | EP | claimed |
| EP-4652181-A1 | POLYCYCLIC PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Janssen Pharmaceutica NV (BE) | 2025-11-26 | — | — | EP | claimed |
| WO-2015191951-A2 | MODULATION OF COMPLEMENT ACTIVITY | RA PHARMACEUTICALS, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| US-20150272934-A1 | USE OF CSE INHIBITORS FOR THE TREATMENT OF CUTANEOUS INJURIES OR CONDITIONS AND SLEEP-RELATED BREATHING DISORDERS | SOVA PHARMACEUTICALS, INC. | 2015-10-01 | — | — | US | claimed |
| EP-2877175-A2 | USE OF CSE INHIBITORS FOR THE TREATMENT OF CUTANEOUS INJURIES OR CONDITIONS AND SLEEP-RELATED BREATHING DISORDERS | Sova Pharmaceuticals, Inc. (US) | 2015-06-03 | — | — | EP | claimed |
| US-20140056812-A1 | Imaging Beta Cell Mass | THE GENERAL HOSPITAL CORPORATION (US) | 2014-02-27 | — | — | US | claimed |
| WO-2014018571-A2 | USE OF CSE INHIBITORS FOR THE TREATMENT OF CUTANEOUS INJURIES OR CONDITIONS AND SLEEP-RELATED BREATHING DISORDERS | SOVA PHARMACEUTICALS, INC. (US) | 2014-01-30 | — | — | WO | claimed |
| US-8466108-B2 | TFPI inhibitors and methods of use | BAXTER INTERNATIONAL INC. (US) | 2013-06-18 | — | — | US | claimed |
| WO-2012121746-A2 | IMAGING BETA CELL MASS | THE GENERAL HOSPITAL CORPORATION (US) | 2012-09-13 | — | — | WO | claimed |
| US-20110263815-A1 | TRIAZOLE MACROCYCLE SYSTEMS | AILERON THERAPEUTICS, INC., A DELAWARE CORPORATION (US) | 2011-10-27 | — | — | US | claimed |
| EP-2379096-A2 | TFPI INHIBITORS AND METHODS OF USE | Baxter International Inc. (US) | 2011-10-26 | — | — | EP | claimed |
| WO-2010071894-A2 | TFPI INHIBITORS AND METHODS OF USE | BAXTER INTERNATIONAL INC. (US) | 2010-06-24 | — | — | WO | claimed |